{
  "CitationSubset": [],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10176483",
  "DateCompleted": {
    "Year": "1998",
    "Month": "03",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0580-7247",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "1",
        "PubDate": {
          "Year": "1998",
          "Month": "Jan"
        }
      },
      "Title": "MLO: medical laboratory observer",
      "ISOAbbreviation": "MLO Med Lab Obs"
    },
    "ArticleTitle": "An emerging superbug. Staphylococcus aureus becomes less susceptible to vancomycin.",
    "Pagination": {
      "StartPage": "26",
      "EndPage": "35",
      "MedlinePgn": "26-32; quiz 34-5"
    },
    "Abstract": {
      "AbstractText": [
        "The name staphylococcus aureus comes from the Greek, staphyle (a bunch of grapes), kokkos (berry shaped), and aureus (golden). Morphologically, the pathogen resembles grapelike clusters of gram-positive cocci. The illustration here shows the bacteria infecting nasal epithelial tissue, and causing cell damage and inflammation. S. aureus has been knocking down our antibiotic defenses one by one, with some strains becoming dangerously less susceptible to vancomycin. Epidemiologists warn that these strains are coming soon to a hospital near you; be prepared by knowing how to identify the bug, notify infection control authorities, and use basic infection control procedures."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Celsis Laboratory Group, Leberco Division, Edison, NJ, USA."
          }
        ],
        "LastName": "Brown",
        "ForeName": "J W",
        "Initials": "JW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Grilli",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "MLO Med Lab Obs",
    "NlmUniqueID": "0225602",
    "ISSNLinking": "0580-7247"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "6Q205EH1VU",
      "NameOfSubstance": "Vancomycin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Microbial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genes, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods",
        "standards"
      ],
      "DescriptorName": "Infection Control"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Population Surveillance"
    },
    {
      "QualifierName": [
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "Staphylococcus aureus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Vancomycin"
    }
  ]
}